Main > ONCOLOGY (**) > Prostate Cancer MET HR *** > TREAT.: > Co: USA. E. DoceTaxel Inj. Non-Alc.
Formula
Co: USA. E. DoceTaxel Inj. Non-Alc.'s subsections
(*) USA Approval Date: 2015. 12.28.
(*) USA Launch Date: 2016. 02.02.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 12.11.
PR Web-Site
TradeMark
Co: USA. E. DoceTaxel Inj. Non-Alc.'s products
This section has no products